A comprehensive guide to all the laws that affect Texas pharmacies on a daily basis, Texas Pharmacy Laws and Regulations is a trusted and indespensable resource for Texas pharmacy professionals. Compiled by our team of expert editors and staff attorneys at LexisNexis in collaboration with the Texas State Board of Pharmacy, this convenient and sturdy softbound volume is tabbed at the outside edge of pages for easy reference when you need to answer a question quickly, and is three-hole-punched so you can easily include it in a reference binder. Inside you'll find coverage of the Texas Pharmacy Act, the Texas Pharmacy Rules, the Texas Controlled Substances Act and Rules, the DEA Pharmacist's Manual, the Texas Dangerous Drug Act, the Texas Food, Drug, and Cosmetic Act, and all the procedures, forms, and addresses you need. Purchasing this regularly updated publication means you can keep abreast of the latest changes in the law, including over-the-counter sales of ephedrine, pseudoephedrine, and norpseudoephedrine. Whether you are a pharmacy technician purchasing a single copy or the manager of a chain of pharmacies purchasing in volume, Texas Pharmacy Laws and Regulations is the resource you need at a price you can afford.

Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.

"Casebook on Constitutional Law for law students"--

The standard legal resource for Texas educators.